Understand the Role of Winlevi for Acne

February 2021

Rx Winlevi (clascoterone) 1% cream will be the first topical androgen receptor inhibitor for treating acne.

Think of Winlevi’s role as similar to spironolactone or OCs for females. It’s a “hormonal” option that can be used regardless of gender.

But don’t get too excited.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

COVID-19 Guide Use of mRNA COVID-19 Vaccines for Special Populations
COVID-19 Know the Ins and Outs of Giving mRNA COVID-19 Vaccines
STIs Shift to Treating Gonorrhea With Just Ceftriaxone
Heart Failure Don’t Jump to Spironolactone or Entresto for HFpEF
COVID-19 Limit Use of Unproven Outpatient Treatments for COVID-19
COVID-19 Point Out Pros and Cons of the Ellume COVID-19 Home Test
Hormone Therapy Be Familiar With Hormone Therapies for Transgender Patients
Gastroenterology Evaluate Appropriate Use of Pancreatic Enzymes
Acne Understand the Role of Winlevi for Acne
Critical Care Have a Plan When ICU Patients Require High Sedative Doses
Inhalers Promote Inhaler Safety and Adherence During Care Transitions